These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 5107863)

  • 21. [Granulocyte transfusion].
    Neppert J; Mueller-Eckhardt C
    Dtsch Med Wochenschr; 1983 Jan; 108(1):3-5. PubMed ID: 6848343
    [No Abstract]   [Full Text] [Related]  

  • 22. [Assessment of a technic for the preparation of deleukocyted blood].
    Engelfriet CP; Diepenhorst P; Veenhoven-von Riesz E; Van Loghem JJ
    Nouv Rev Fr Hematol; 1974; 14(4):547-55. PubMed ID: 4280565
    [No Abstract]   [Full Text] [Related]  

  • 23. Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors.
    Teshima T; Matsuo K; Matsue K; Kawano F; Taniguchi S; Hara M; Hatanaka K; Tanimoto M; Harada M; Nakao S; Abe Y; Wake A; Eto T; Takemoto Y; Imamura M; Takahashi S; Ishida Y; Kanda Y; Kasai M; Takaue Y
    Br J Haematol; 2005 Aug; 130(4):575-87. PubMed ID: 16098073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevention of posttransfusion complications].
    Filatov AN
    Probl Gematol Pereliv Krovi; 1966 Mar; 11(3):3-7. PubMed ID: 5993339
    [No Abstract]   [Full Text] [Related]  

  • 25. Febrile transfusion reactions caused by leucocyte antibodies.
    Dalton NT; Schollum KM
    N Z Med J; 1968 May; 67(432):547-50. PubMed ID: 5243027
    [No Abstract]   [Full Text] [Related]  

  • 26. [Blood transfusion: compatibility of preserved blood with intravenous solutions].
    Pastoret i Pascal C; Giró i Molner MT
    Rev Enferm; 1985 May; 8(82):47-50. PubMed ID: 3847112
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunologic factors in reactions to blood transfusions.
    McLeod BC
    Heart Lung; 1980; 9(4):675-81. PubMed ID: 6773907
    [No Abstract]   [Full Text] [Related]  

  • 28. Transfusion-associated graft-versus-host disease.
    Dwyre DM; Holland PV
    Vox Sang; 2008 Aug; 95(2):85-93. PubMed ID: 18544121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leukocyte depletion of cellular blood components.
    Lane TA
    Curr Opin Hematol; 1994 Nov; 1(6):443-51. PubMed ID: 9371321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantation.
    Prigozhina TB; Elkin G; Khitrin S; Slavin S
    Exp Hematol; 2008 Dec; 36(12):1750-9. PubMed ID: 18809241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of leucocyte poor blood. A comparison of five different methods.
    Grunnet N; Rasmussen NJ
    Scand J Urol Nephrol Suppl; 1981; 64():106-11. PubMed ID: 6959257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch.
    Scholl S; Klink A; Mügge LO; Schilling K; Höffken K; Sayer HG
    Transfusion; 2005 Oct; 45(10):1676-83. PubMed ID: 16181220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leukocyte typing and kidney transplantation in unrelated donor-recipient pairs. A study in patients of Drs. S. Peart, J.F.Mowbray, and G.R.J. Alexandre.
    Pearce R; van Rood JJ; van Leeuwen A; van der Does JA
    Transplant Proc; 1969 Mar; 1(1):372-5. PubMed ID: 4944241
    [No Abstract]   [Full Text] [Related]  

  • 34. [Washing and filtration of blood components: which indications are established?].
    Neppert J
    Beitr Infusionsther; 1993; 31():64-9. PubMed ID: 7693266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of GVHD after blood transfusion.
    Sakuma H; Kikuta A; Suzuki H
    Fukushima J Med Sci; 1993 Dec; 39(2):113-6. PubMed ID: 7927134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The graft-vs-host reaction in military transfusion treatment].
    Shevchenko IuL; Danil'chenko VV; Zhiburt EB; Serebrianaia NB; Katkova IV; Khubulava GG
    Voen Med Zh; 1997 Feb; 318(2):32-5. PubMed ID: 9148576
    [No Abstract]   [Full Text] [Related]  

  • 37. Cyclosporin A and mini short-term methotrexate vs cyclosporin A as graft-versus-host disease prophylaxis in patients with beta thalassemia major undergoing allogeneic blood and marrow transplantation.
    Iravani M; Mousavi A; Gholibeikian S; Bahar B; Samiee S; Ashouri A; Eghbal L; Ghavamzadeh A
    Bone Marrow Transplant; 2005 Jun; 35(11):1095-9. PubMed ID: 15821773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Preparation of an erythrocyte concentrate from whole blood in plastic packs for patients with previous febrile reactions to transfusion].
    Gundolf F
    Ugeskr Laeger; 1976 Aug; 138(34):2059-61. PubMed ID: 968957
    [No Abstract]   [Full Text] [Related]  

  • 39. Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. BCSH Blood Transfusion Task Force.
    Transfus Med; 1996 Sep; 6(3):261-71. PubMed ID: 8885157
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevention of post-transfusion graft-versus-host disease.
    Tasaki T; Ohto H; Abe R
    Fukushima J Med Sci; 1993 Dec; 39(2):109-11. PubMed ID: 7927133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.